Are We Over-Diagnosing Cannabis Use Disorder in Prescribed Medical Cannabis Patients?
prescription cannabis use disorder: A new Addiction journal study of 2,054 Australians prescribed medical cannabis found that removing tolerance and withdrawal from Cannabis Use Disorder criteria cut apparent disorder rates among as-prescribed patients…
THC:CBD Oil for Spinal Cord Injury Spasticity- What a Pilot Trial Found
THC CBD oil for spinal cord injury spasticity: A placebo-controlled crossover pilot tested balanced THC:CBD oil in 16 people with chronic spinal cord injury. The objective primary spasticity measure did not significantly improve, while one patient-rated…
CBD and Nonseizure Outcomes in Epilepsy: What a New Systematic Review Shows
This systematic review examines CBD nonseizure outcomes epilepsy, analyzing 32 studies with 1,343 patients. It reports consistent improvements in cognition, behavior, and other nonseizure domains, though evidence is mostly observational and requires…
Dronabinol Cuts PTSD Nightmares in a New Randomized Trial
Dronabinol PTSD nightmares: a randomized, placebo-controlled trial in more than 170 adults found nightly oral THC significantly reduced PTSD-related nightmares over 10 weeks. More than a third of treated patients became nightmare-free. Overall PTSD…
Cannabis Use, Cannabis Use Disorder Are Not The Same
Cannabis use and cannabis use disorder showed partly different genetic relationships with selected brain-imaging traits in a large 2026 analysis. The findings support treating use and disorder as related but noninterchangeable research phenotypes. They…
Cannabinoids for MS Spasticity: What 27 Randomized Trials Show
cannabinoids for MS spasticity: A systematic review of 27 randomized trials found modest patient-reported improvement in multiple-sclerosis spasticity, especially with THC:CBD extracts. Objective benefits were limited and the certainty of evidence was…
Prenatal Cannabis Use and Motivation to Quit: What a New Study Found
prenatal cannabis use: A study of 176 pregnant adults found that several motivation measures were associated with less self-reported cannabis use. The secondary observational analysis cannot show that motivation or a specific intervention caused reduced…
FAA Initiates Cannabis Rescheduling Review for Pilot Fitness-for-Duty
The FAA cannabis rescheduling pilot fitness-for-duty review is underway, examining how federal rescheduling affects drug testing and certification for pilots and air traffic controllers. This process will inform future FAA cannabis policies but does not…
CED Cannabis Science Digest: CBD and Macrophage Inflammation, Texas Compassionate Use Access
CBD macrophage inflammation: A controlled human cell-culture study found CBD selectively reduced part of the inflammatory response in lipid-stressed macrophages, and a separate policy analysis argues Texas should add dialysis patients as a qualifying…
UK Medical Cannabis Use: What a New National Survey Found
A new UK national survey examined uk medical cannabis prescriptions and their link to high-risk use. The study found prescribed users more frequently used processed products and screened positive for high-risk use. These findings highlight the need for…